Other disclosuresNSE · PPLPHARMA
Piramal Pharma Limited
News Verification
01 / The disclosure
What the company shared
The Exchange has sought clarification from Piramal Pharma Limited with respect to recent news item captioned Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharmas Aurora Facility.. The response from the Company is attached.
Exchange-provided summary Company profile
A question for your research
Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.
The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106805478
- First collected
- 3 Oct 2026, 17:17 IST
- PDF extraction
- pending
You’ve reached the end of this disclosure.